Observation on the Effect of Xiaoqinglong Plus Gypsum Decoction in Treating Asthmatic Bronchopneumonia in Children

February 1, 2026

View at Publisher

Ask AI

Bookmark

Share

Key Points

To observe the clinical efficacy of Xiaoqinglong plus Gypsum Decoction in conjunction with conventional Western treatment for asthmatic bronchopneumonia in children.
80 children with asthmatic bronchopneumonia were enrolled from September 2024 to June 2025.
Participants were divided into an observation group (Xiaoqinglong and Gypsum Decoction) and a control group (conventional treatment).
The treatment effects, symptom relief times, traditional Chinese medicine symptom scores, and inflammatory markers were compared.
The observation group had a significantly higher total effective rate compared to the control group (P<0.05).
Symptom and sign resolution times were shorter in the observation group than in the control group (P<0.05).
Post-treatment inflammatory markers (CRP, IL-8, PCT) were lower in the observation group than in the control group, with significant differences (P<0.05).

Answers are grounded in this paper and cite their sources.

Shows improved clinical efficacy in treating asthmatic bronchopneumonia in children, suggesting a beneficial adjunctive therapy.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

HE et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share